4M7-26104-66666
3 vaccinations
4 coded responses
29 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 457 / OH
- Registered
- 2022-07-30
- Relationship
- Child or adolescent in my care
- Guardian
- F2R-33969-38488
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-29
Dose 1 — Pfizer-BioNTech
-
2022-07-30
Registered in v-safe
- 2022-07-30
- 2022-08-01
- 2022-08-03
- 2022-08-04
- 2022-08-05
- 2022-08-12
-
2022-08-19
Dose 2 — Pfizer-BioNTech
- 2022-08-19
- 2022-08-21
- 2022-08-22
- 2022-08-23
- 2022-08-24
- 2022-08-25
- 2022-08-26
- 2022-09-02
-
2022-09-09
Survey response — day 21, dose 2, dependentMedDRA: Cough, Laryngitis, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend schoolFree text: Laryngitis, mild cough, mild congestionMedDRA releases: 2024-11 · check-in free text available
- 2022-09-16
- 2022-09-23
- 2022-09-30
-
2022-10-21
Dose 3 — Pfizer-BioNTech
- 2022-10-24
- 2022-10-26
- 2022-10-27
- 2022-10-28
- 2022-11-04
- 2022-11-12
-
2022-11-18
Survey response — day 28, dose 3, dependentMedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend schoolFree text: Head coldMedDRA releases: 2024-11 · check-in free text available
- 2022-11-25
-
2022-12-02
Survey response — day 42, dose 3, dependentMedDRA: Respiratory tract congestion, Sneezing — Feeling: GoodFree text: Congestion, sneezingMedDRA releases: 2024-11 · check-in free text available
- 2023-01-20
-
2023-04-21
Survey response — 6 months, dose 3, dependentMedDRA: COVID-19, Pharyngitis streptococcal — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-04-21
Report sent to call center — 6 months, dose 3, dependentBe unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-04-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-29 | Pfizer-BioNTech | No |
| 2 | 2022-08-19 | Pfizer-BioNTech | No |
| 3 | 2022-10-21 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 12 — day 21, dose 2, dependent
Symptoms: Laryngitis, mild cough, mild congestion
Release 12 — day 28, dose 3, dependent
Symptoms: Head cold
Release 12 — day 42, dose 3, dependent
Symptoms: Congestion, sneezing
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Laryngitis | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pharyngitis streptococcal | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release